Gynaecological Group

The NCRI Gynaecological Group is a multi-disciplinary community of researchers and consumers focused on clinical and translational issues relating to gynaecological cancer research. The group works closely with clinical research networks, funders and national and international researchers to develop research to improve outcomes for gynaecological cancer patients and identify areas of unmet need.

The group routinely identifies priorities in gynaecological cancer research and dynamic working groups are established to address each priority.

NCRI Gynaecological Group strategic priorities:

  • Early detection
  • Personalised medicine
  • Rare cancer: vulval cancer
  • Improve wellbeing in women undergoing treatment for gynaecological cancers

NCRI Gynaecological Group strategic priorities

How can I get involved?

Join the NCRI Gynaecological Network

Group members

Dr Shibani Nicum

Chair

Dr Shibani Nicum is a Consultant Medical Oncologist, specialising in ovarian and other gynaecolog ...

Dr Shibani Nicum

Chair

Dr Shibani Nicum is a Consultant Medical Oncologist, specialising in ovarian and other gynaecological cancers and is based at the Oxford Cancer Centre, in addition to seeing private patients at a variety of hospitals, including in London. Dr Nicum is a graduate of Birmingham Medical School and then completed specialist oncology training at the Royal Marsden Hospital in London, before taking up her role in Oxford in 2009. She is the Lead Clinician for the Gynaecology Unit, the Oxford Multidisciplinary Team and the Thames Valley Gynaecology Alliance Group.

Dr Rebecca Bowen

Deputy Chair

Rebecca Bowen is a medical oncologist, specializing in breast and gynaecological cancers and lead ...

Dr Rebecca Bowen

Deputy Chair

Rebecca Bowen is a medical oncologist, specializing in breast and gynaecological cancers and leads a multidisciplinary oncology menopause service in Bath.  She graduated from University of Nottingham Medical School and trained in oncology at St Bartholomew’s Hospital.  Rebecca was awarded the Cancer Research UK Gordon Hamilton Fairley Research Fellowship for her PhD at the Barts Cancer Institute and completed training at the Early Phase Trials Unit at the Royal Marsden.

Rebecca is Clinical Director for Oncology and the research lead for Oncology and Haematology in Bath. She is also a visiting professor at the University of Bath and the Clinical Research Specialty Lead for Gynae Oncology for the West of England. Rebecca is co-chair for UKGOM and a member of UKBCG.

 

More from NCRI